Antiretroviral therapy in public and private routine health care clinics in Cameroon:: Lessons from the Douala antiretroviral (DARVIR) initiative

被引：31

作者：

Laurent, C

Meilo, H

Guiard-Schmid, JB

Mapouré, Y

Noël, JM

M'Bangué, M

Joko, A

Rozenbaum, W

Ntoné, FN

Delaporte, E

机构：

[1] Univ Montpellier, UMR 145, Inst Rech Dev, F-34394 Montpellier, France

[2] Univ Montpellier, UMR 145, Dept Int Hlth, F-34394 Montpellier, France

[3] Univ Paris 06, Hop Tenon, Dept Infect & Trop Dis, F-75252 Paris, France

[4] Hop Laquintinie, Douala, Cameroon

[5] Hop Gen, Douala, Cameroon

来源：

CLINICAL INFECTIOUS DISEASES | 2005年 / 41卷 / 01期

关键词：

D O I：

10.1086/430712

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A review of the hospital charts for 788 patients treated in 19 public and private clinics in Cameroon showed that clinical follow-up visits, biologic follow-up visits, and drug supply were irregular and that many patients interrupted treatment. Virological and immunologic effectiveness of therapy was as expected in patients for whom results were available.

引用

收藏

页码：108 / 111

页数：4

相关论文

共 14 条

[1]

Adjé C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018

[2] Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults [J].

Bartlett, JA ;

DeMasi, R ;

Quinn, J ;

Moxham, C ;

Rousseau, F .

AIDS, 2001, 15 (11) :1369-1377

[3]

Bourgeois A, 2005, ANTIVIR THER, V10, P335

[4] Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa [J].

Coetzee, D ;

Hildebrand, K ;

Boulle, A ;

Maartens, G ;

Louis, F ;

Labatala, V ;

Reuter, H ;

Ntwana, N ;

Goemaere, E .

AIDS, 2004, 18 (06) :887-895

[5] Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Cote d'Ivoire [J].

Djomand, G ;

Roels, T ;

Ellerbrock, T ;

Hanson, D ;

Diomande, F ;

Monga, B ;

Maurice, C ;

Nkengasong, J ;

Konan-Koko, R ;

Kadio, A ;

Wiktor, S ;

Lackritz, E ;

Saba, J ;

Chorba, T .

AIDS, 2003, 17 :S5-S15

[6] The Senegalese government's highly active antiretroviral therapy initiative:: an 18-month follow-up study [J].

Laurent, C ;

Diakhaté, N ;

Gueye, NFN ;

Touré, MA ;

Sow, PS ;

Faye, MA ;

Gueye, M ;

Lanièce, I ;

Kane, CT ;

Liégeois, F ;

Vergne, L ;

Mboup, S ;

Badiane, S ;

Ndoye, I ;

Delaporte, E .

AIDS, 2002, 16 (10) :1363-1370

[7] Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults [J].

Laurent, C ;

Gueye, NFN ;

Ndour, CT ;

Gueye, PM ;

Diouf, M ;

Diakhaté, N ;

Kane, NCT ;

Lanièce, I ;

Ndir, A ;

Vergne, L ;

Ndoye, I ;

Mboup, S ;

Sow, PS ;

Delaporte, E .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (01) :14-17

[8] Antiretroviral therapy in a primary care clinic in rural South Africa [J].

Livesley, N ;

Morris, C .

AIDS, 2003, 17 (13) :2005-2006

[9] Antiretroviral therapy in the private sector of Nairobi, Kenya: a review of the experience of five physicians [J].

Macharia, DK ;

Chang, LW ;

Lule, G ;

Owili, DM ;

Tesfaledet, G ;

Patel, S ;

Silverstein, DM ;

Ng'ang'a, L ;

Bush, T ;

De Cock, KM ;

Weidle, PJ .

AIDS, 2003, 17 (06) :938-940

[10]

Seyler C, 2003, ANTIVIR THER, V8, P385